Valuation: DiaSorin S.p.A.

Market Cap 3.76B 4.27B 3.51B 3.22B 6.02B 409B 6.17B 41.57B 16.26B 203B 16.05B 15.7B 700B P/E 2026 *
20.4x
P/E 2027 * 18x
Enterprise Value 4.42B 5.04B 4.13B 3.79B 7.1B 482B 7.27B 48.98B 19.15B 239B 18.91B 18.5B 825B EV / Sales 2026 *
3.61x
EV / Sales 2027 * 3.29x
Free-Float
37.17%
Yield 2026 *
1.85%
Yield 2027 * 1.94%
1 day+0.34%
1 week+5.10%
Current month+4.57%
1 month+3.69%
3 months+22.30%
6 months-1.34%
Current year+3.26%
1 week 63
Extreme 63
71.48
1 month 63
Extreme 63
71.78
Current year 52.34
Extreme 52.34
77.64
1 year 52.34
Extreme 52.34
92.32
3 years 52.34
Extreme 52.34
112.35
5 years 52.34
Extreme 52.34
208.8
10 years 49.98
Extreme 49.98
211.8
Manager TitleAgeSince
Chief Executive Officer 60 26/03/2007
Director of Finance/CFO - 01/01/2025
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 60 28/04/2016
Director/Board Member 63 26/03/2007
Chairman 57 29/04/2022
Date Insider Type Main position Quantity % Market Cap.
24/03/26 Buy

Chief Executive Officer

9,211 0.0165%
28/01/26 Buy

Chief Executive Officer

7,500 0.0134%
08/01/26 Buy

Director

1,000 0.0018%
Change 5-day change 1-year change 3-year change Capi.($)
+0.34%+5.10%-21.46%-30.05% 4.26B
+0.31%-4.43%+232.57%+269.22% 19.04B
-2.80%+3.48%-41.63%-25.88% 10.07B
-2.57%-4.41%+38.50%+15.62% 6.68B
-1.55%-1.55%+230.86%-26.45% 5.97B
+0.31%+4.14%-15.57%-20.65% 5.53B
0.00%+1.37%-43.35% - 4.41B
-0.33%-16.23%+70.56%+88.36% 4.15B
+2.54%+0.15%-18.58%-43.19% 2.69B
-0.90%-15.99%-43.15%+171.99% 1.45B
Average -0.47%-1.88%+38.88%+44.33% 6.43B
Weighted average by Cap. -0.64%-1.70%+84.92%+84.69%

Financials

2026 *2027 *
Net sales 1.23B 1.4B 1.15B 1.05B 1.97B 134B 2.02B 13.58B 5.31B 66.18B 5.24B 5.13B 229B 1.3B 1.48B 1.22B 1.12B 2.09B 142B 2.14B 14.44B 5.65B 70.37B 5.57B 5.45B 243B
Net income 182M 208M 170M 156M 292M 19.88B 300M 2.02B 789M 9.84B 779M 762M 34B 205M 233M 191M 176M 329M 22.36B 337M 2.27B 888M 11.07B 877M 858M 38.26B
Net Debt 669M 761M 625M 573M 1.07B 72.93B 1.1B 7.41B 2.9B 36.09B 2.86B 2.8B 125B 539M 614M 503M 462M 865M 58.79B 886M 5.97B 2.33B 29.09B 2.3B 2.25B 101B
Logo DiaSorin S.p.A.
DiaSorin S.p.A. specializes in the development, manufacturing and marketing of in vitro diagnostic reagents. The products are used in treating infectious and viral diseases, thyroid pathologies, cancer, etc. At the end of 2025, the group had 9 production sites located in Italy, the United States (4), Canada, Germany, the United Kingdom and Chine. Net sales are distributed geographically as follows: Italy (15.2%), Europe (24.9%), North America (51.8%), and other (8.1%).
Employees
3,242
Date Price Change Volume
29/07/26 70.86 +0.34% 279,951
28/07/26 €70.62 +5.28% 486,326
27/07/26 €67.08 +0.51% 168,973
24/07/26 €66.74 -0.12% 151,611
23/07/26 €66.82 -0.27% 116,775
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
70.62EUR
Average target price
70.45EUR
Spread / Average Target
-0.24%

Quarterly revenue - Rate of surprise